Fig. 3: PFSratio-based comparison of precision oncology clinical trials.

a S_PFSratio(δ), b median PFSratio Vertical dotted lines identify 0.8, 1, 1.3, and 1.5 points on the x axis. Abbreviations: MTA molecularly targeted agent, PFS progression free survival, PFSratio progression free survival ratio, TPC treatment of physician’s choice.